HighPoint Advisor Group’s Takeda Pharmaceutical TAK Stock Holding History

HighPoint Advisor Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$214K	Buy	+14,995	New	+$214K	0.02%	479
2021 Q3	$189K	Buy	11,515 +671	+6%	+$11.3K	0.02%	522
2021 Q2	$183K	Sell	10,844 -531	-5%	-$9.04K	0.02%	514
2021 Q1	$196K	Buy	11,375 +259	+2%	+$4.66K	0.02%	463
2020 Q4	$197K	Buy	+11,116	New	+$195K	0.02%	439
2020 Q2	–	Sell	-10,607	Closed	-$186K	–	374
2020 Q1	$186K	Buy	10,607 +50	+0.5%	+$906	0.04%	306
2019 Q4	$212K	Buy	10,557 +47	+0.4%	+$899	0.04%	321
2019 Q3	$210K	Sell	10,510 -227	-2%	-$3.93K	0.05%	307
2019 Q2	$184K	Buy	+10,737	New	+$195K	0.04%	328
2019 Q1	–	Sell	-10,563	Closed	-$213K	–	354
2018 Q4	$213K	Buy	+10,563	New	+$178K	0.06%	282

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighPoint Advisor Group's TAK Position: Q2 2022 in Review

HighPoint Advisor Group opened a new position in Takeda Pharmaceutical (TAK) in Q2 2022: 14,995 shares worth $214K. The stake represents 0.02% of the portfolio and ranks #479 among its holdings. This is a return to the name: HighPoint Advisor Group previously reported a position in TAK as recently as Q3 2021.

HighPoint Advisor Group first reported a position in TAK in Q4 2018 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

HighPoint Advisor Group held 14,995 shares of Takeda Pharmaceutical worth $214K as of Q2 2022.
Takeda Pharmaceutical was a new HighPoint Advisor Group position in Q2 2022.
Takeda Pharmaceutical made up 0.02% of HighPoint Advisor Group's portfolio in Q2 2022, its #479 holding.
HighPoint Advisor Group first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 10 quarters since.
282 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on HighPoint Advisor Group's 13F filing for Q2 2022, filed 15 Aug 2022.